drugset / Trial / NCT01821573

Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength During Locomotion in Chronic Hemiparetic Patients

NCT01821573 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this randomized controlled study is to quantify the modification during locomotion of chronic hemiparetic patients of the strength and the length of Rectus Femoris and Triceps Surae induced by botulinum toxin injection type A. The main hypotheses of this study based on previous studies are that botulinum toxin injection increases on one hand the length of the muscle injected during gait and on the other hand decreased the strength of the muscles injected. The investigators also hypothesized that botulinum toxin injection improved the strength of the antagonist muscles and normalized the pattern of strength of the muscles injected during gait.

Timeline

Start
2013-07
Primary completion
2017-09-05
Completion
2019-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 60 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 70 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 150 iu Intramuscular

Indications

No indication recorded.